See more
FDA-Approved VYZULTA® | View Dosing & Prescribing Info
Sponsored (latanoprostene bunod ophthalmic solution), 0.024%. Learn More About VYZULTA® Treat…Available Savings Options · Mechanism of Action · View Pivotal Study Data
Types: Prescribing Information, Sign Up For Updates, Access Video Resources
